Congress Won’t Stop Trading Stocks
Researchers studying congressional stock ownership have found that the practice has effects on lobbying activity and potentially on market movements.
Influence
Page 7
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Paul Pelosi Invests in Alphabet as Congress Weighs Breaking Up Big Tech
So far this year, Paul Pelosi has purchased stock in companies including Tesla, Walt Disney, Apple, Facebook, and Amazon.
Feigning Shock Over Lobbyist Comments, ExxonMobil Continues Funding Climate Denial Groups
ExxonMobil’s most recent worldwide giving report, covering 2019, shows it funds multiple climate denial groups.
Big Tech-Funded Groups Lobby Against Antitrust Bills
Last week, the House Judiciary Committee approved a sweeping package of antitrust bills, one overcoming opposition from Democrats hailing from tech industry-heavy California.
House Dems Launch PAC to Fight Progressive Primary Challengers
Its founders are among the top fundraisers from corporate PACs in the House Democratic caucus.
Dems Signaling Opposition to Pelosi’s Drug Pricing Bill Got 2.5x More Pharma Money
On average, the signers received $93,275 from the pharmaceutical & health products industry in the 2020 cycle, far more than the average for House Democrats of $37,788.
Koch Group Fights Drug Price Reforms After Taking Big Pharma Money
Americans for Prosperity is hitting six key moderate House Democrats with digital ads opposing reintroduced drug pricing measures.
After Assessing the Insurrection, Toyota's PAC Donates to Election Objectors
The automaker took just three weeks to assess the Jan. 6 riots before restarting PAC donations to Republican election objectors.
The Saudi Expert Who Hides Foreign Funding When Testifying to Congress
A former Trump official sidestepped a new ethics rule.